Co-Occurring Disorders Editor · Last reviewed January 2025
The co-occurrence of bipolar disorder and substance use disorders is one of the most clinically significant presentations in behavioral health treatment. Understanding how these two conditions interact, which came first, and how integrated treatment addresses both simultaneously is essential for effective care.
Prevalence and the Bidirectional Relationship
Bipolar disorder has among the highest comorbidity rates with substance use disorders of any mental health condition — 40–60% lifetime comorbidity in most studies. Alcohol use disorder is most common, followed by cannabis and stimulant use. Substance use during manic episodes is particularly dangerous: it amplifies impulsivity, risky behavior, and the severity of mood episodes, and can trigger mixed states or rapid cycling that significantly complicate treatment. The relationship is bidirectional and mutually reinforcing: mental health symptoms drive substance use as self-medication, and substance use worsens, triggers, or maintains mental health symptoms through direct neurobiological effects and disruption of sleep, social functioning, and daily routines.
Diagnostic Complexity
Accurately diagnosing both conditions in the context of active substance use is challenging. Many substances produce psychiatric symptoms during intoxication or withdrawal that mimic primary mental health conditions. Comprehensive dual diagnosis assessment by a clinician trained in both areas — ideally after a period of sobriety or stable use — is essential. That said, severe psychiatric symptoms may require immediate treatment regardless of substance use status.
Why Sequential Treatment Often Fails
When mental health symptoms are driving substance use as self-medication, leaving those symptoms untreated undermines sobriety. When substance use is maintaining psychiatric symptoms through neurobiological dysregulation or psychological avoidance, leaving addiction untreated undermines psychiatric treatment. Integrated simultaneous treatment consistently outperforms sequential approaches in the research literature.
Integrated Treatment
Mood stabilization is the pharmacological priority — unstabilized mood episodes fuel substance use and undermine behavioral treatment. Lithium has the strongest evidence base for bipolar disorder with antisuicidal effects; valproate is a commonly used alternative with some evidence suggesting utility specifically in bipolar with co-occurring alcohol use disorder. Antidepressants require caution in bipolar — they can trigger manic episodes and are not used as monotherapy. MAT for co-occurring opioid or alcohol use disorder should be provided where indicated. Interpersonal and Social Rhythm Therapy (IPSRT), which targets irregular sleep and daily routines that trigger mood episodes, is particularly well-suited to the dual diagnosis context where substance use disrupts circadian regularity.
Finding Integrated Treatment
SAMHSA's National Helpline (1-800-662-4357) and treatment locator at findtreatment.gov identify programs with dual diagnosis specialty. When evaluating programs, ask specifically whether both conditions are treated simultaneously, whether a psychiatric prescriber is on staff, and what evidence-based co-occurring disorders treatments are used.
Related: Medication Management · Bipolar Disorder Overview · Alcohol & Mental Health